IVA
Inventiva S.A.
NASDAQ · Healthcare · Biotechnology · FR
$4.78
−1.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.53x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -33.45x
- Price / sales
- 71.00x
- Price / cash flow
- -5.01x
Enterprise value
- Enterprise value
- $1.1B
- EV / sales
- 68.09x
- EV / EBITDA
- -2.27x
- EV / EBIT
- -4.08x
- Market cap
- $1.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025